Title

Urinary biomarkers of bladder cancer: an update and future perspectives

Authors

Authors

C. J. Rosser; V. Urquidi;S. Goodison

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Biomark. Med.

Keywords

biomarker; bladder cancer; genomics; metabolomics; proteomics; urinary; cytology; urine; TRANSITIONAL-CELL CARCINOMA; IN-SITU HYBRIDIZATION; NUCLEAR-MATRIX; PROTEIN-22; POLYMERASE-CHAIN-REACTION; CARE PROTEOMIC ASSAY; BTA TRAK; ASSAY; UROTHELIAL CARCINOMA; VOIDED-URINE; GENE-EXPRESSION; FOLLOW-UP; Medicine, Research & Experimental

Abstract

Bladder cancer is one of the most prevalent cancers worldwide. Early detection of bladder tumors is critical for improved patient outcomes. The standard method for detection and surveillance of bladder tumors is cystoscopy with urinary cytology. Limitations of cystoscopy and urinary cytology have brought to light the need for more robust diagnostic assays. Ideally, such assays would be applicable to noninvasively obtained, voided urine, and be designed not only for diagnosis, but also for monitoring disease recurrence and response to therapy. Consequently, the development of a noninvasive urine-based assay would be of tremendous benefit to both patients and healthcare systems. This article reports some of the more prominent urine-based biomarkers reported in the literature. In addition, some new technologies that have been used to identify novel urinary biomarkers are highlighted.

Journal Title

Biomarkers in Medicine

Volume

7

Issue/Number

5

Publication Date

1-1-2013

Document Type

Review

Language

English

First Page

779

Last Page

790

WOS Identifier

WOS:000324474800018

ISSN

1752-0363

Share

COinS